Rekha Hemrajani
Director/Board Member at MAXCYTE, INC.
Net worth: 50 610 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jaume Pons | M | 58 |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | 9 years |
| Srini Akkaraju Akkaraju | M | 56 | 4 years | |
| Maher Masoud | M | 49 | - | |
| Ron Holtz | M | 66 | 19 years | |
| Eric Morgen | M | - |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | - |
| Laurent Fischer | M | 60 | 4 years | |
| Richard D. van Doren | M | 47 | 4 years | |
| Richard Douglas | M | 71 | 6 years | |
| Graham Walmsley | M | 37 |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | 4 years |
| Peter Soparkar | M | 53 | 5 years | |
| Kristen Fortney | M | - |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | - |
| Jason Lettmann | M | 46 | 4 years | |
| Peter García | M | 62 | 4 years | |
| Reed Tuckson | M | 73 | 3 years | |
| Steve Kelsey | M | 63 | 4 years | |
| David Sandoval | M | 46 | 1 years | |
| Yasir Al-Wakeel | M | 42 | 3 years | |
| Michael Giordano | M | 66 | 6 years | |
| Dawn Svoronos | F | 70 | 4 years | |
| Patrick Haley | M | 48 | 14 years | |
| Jason V. Coloma | M | - |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | 3 years |
| Linda Kozick | F | 66 | 8 years | |
| Madhu Vikram Utamsingh | M | - |
Hemmo Pharmaceuticals Pvt Ltd.
 Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | - |
| Mark Lupher | M | 53 | 5 years | |
| Heikki Jouttijärvi | M | - | 4 years | |
| Dan Spiegelman | M | 65 | 4 years | |
| Patrick Balthrop | M | 67 | 2 years | |
| Scott Whitcup | M | 64 | 4 years | |
| Richard Rodgers | M | 57 | 9 years | |
| Douglas Swirsky | M | 54 | 1 years | |
| Jack Wyszomierski | M | 68 | 20 years | |
| Art Mandell | M | 71 | 18 years | |
| George Poste | M | 79 | 20 years | |
| John Johnston | M | 65 | 8 years | |
| Fred Eshelman | M | 76 | 4 years | |
| Corey Goodman | M | 72 | 9 years | |
| Will Brooke | M | 68 | 20 years | |
| Stanley Erck | M | 76 | 19 years | |
| Jim Scopa | M | 65 | 5 years | |
| Sophia Randolph | M | 56 | 8 years | |
| Gene Zhu | M | - | - | |
| Suresh Chandumal Vazirani | M | - |
Hemmo Pharmaceuticals Pvt Ltd.
Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | - |
| Shelly Pinto | F | 48 | 3 years | |
| Hong I. Wan | M | - | 9 years | |
| Bill Tan | M | - | 3 years | |
| Athanasios Tsiatis | M | - | 3 years | |
| Ali Soleymannezhad | M | - | 1 years | |
| Jill Mayer | F | - | 6 years | |
| Hank Stern | M | - | 9 years | |
| Dov Goldstein | M | 56 |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | 3 years |
| Dena House | F | - | 5 years | |
| Lisa Moore | M | - | 6 years | |
| Eric Matthews | M | - | 5 years | |
| Vijay Pande | M | 53 |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | - |
| James Brady | M | - | - | |
| Laura Dillard | F | - | 19 years | |
| Thomas Ross | M | 63 | 10 years | |
| Chris Byrd | M | - | 2 years | |
| Michael Chang | M | - | 9 years | |
| Robert J. Adelman | M | 61 |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | - |
| Steven Nardi | M | - | 4 years | |
| J. Garland | M | 55 | 2 years | |
| Dirk Brockstedt | M | 55 | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul Cleveland | M | 67 | 4 years | |
| Doug Doerfler | M | 68 | 25 years | |
| Jay Shepard | M | 66 | 7 years | |
| David J. Scott | M | 71 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Geoff Duyk | M | 64 | 7 years | |
| Christopher J. DeRespino | M | 43 | - | |
| Jennifer Cheng | M | 51 | 4 years | |
| Jason Barker | M | 54 | 1 years | |
| Jack Nielsen | M | 60 | 4 years | |
| Mohammed Malik | M | 56 | - | |
| James Bucher | M | 59 | 7 years | |
| Eric J. Hall | M | 69 | - | |
| Pamela Klein | M | 63 | - | |
| Cory Freedland | M | 48 | 2 years | |
| Angela Thedinga | F | 42 | 2 years | |
| Lori Friedman | M | 60 | - | |
| Myesha Lacy | F | - | - | |
| Jennifer Drimmer | F | - | 14 years | |
| Mitchell Finer | M | 65 | 13 years | |
| Thomas Wiggans | M | 72 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 8 years |
| Robert Hoffman | M | 58 | 2 years | |
| Eric Carter | M | 72 | 4 years | |
| Francis McCormick | M | 73 | 11 years | |
| Perry Karsen | M | 69 | 1 years | |
| Christoph Pereira | M | 51 | 3 years | |
| Alan Garber | M | 68 | 19 years | |
| Carl Feldbaum | M | 80 | 16 years | |
| J. Stark Thompson | M | 82 | 20 years | |
| Pablo Cagnoni | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Antonio J. Grillo-López | M | 84 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 11 years |
| Paul Goddard | M | 74 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 16 years |
| Glen Y. Sato | M | 65 | 4 years | |
| Wendell Wierenga | M | 76 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 17 years |
| Magnus Åke Lundberg | M | 68 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 13 years |
| William Ringo | M | 78 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Itziar Canamasas | M | 50 | 2 years | |
| Carol Hoang | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 98 | 98.00% |
| India | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Rekha Hemrajani
- Personal Network
